The Patent Finder

Tel-Aviv University Future Technology Development L.P.

Also on record
Records under this name other than patents Tel-Aviv University Future Technology Development L.P. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Tel-Aviv University Future Technology Development L.P.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,629,824Indole Derivatives and Process for Their Preparation
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,630,989Dipeptide Analogs for Treating Conditions Associated with Amyloid Fibril Formation
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,178,129Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostic and therapy
Lapsed on the fee record
Ended May 15, 2024 · USPTO record
Lapsed on the fee recordEnded May 15, 2024USPTO record
US 8,563,273Method of screening for compounds that disaggregate amyloid aggregates
Term ended
Term ended Apr 4, 2024 · USPTO record
Term endedTerm ended Apr 4, 2024USPTO record
US 7,446,092Glycogen Synthase KINASE-3 Inhibitors
Term ended
Term ended Feb 28, 2024 · High confidence
Term endedTerm ended Feb 28, 2024High confidence
US 7,544,374Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
Term ended
Term ended Feb 27, 2024 · USPTO record
Term endedTerm ended Feb 27, 2024USPTO record
US 9,259,474Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
Lapsed on the fee record
Ended Feb 16, 2024 · USPTO record
Lapsed on the fee recordEnded Feb 16, 2024USPTO record
US 8,697,634Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
Term ended
Term ended Nov 23, 2023 · USPTO record
Term endedTerm ended Nov 23, 2023USPTO record
US 7,907,998Bio-impedance apparatus and method
Lapsed on the fee record
Ended Mar 15, 2023 · USPTO record
Lapsed on the fee recordEnded Mar 15, 2023USPTO record
US 7,781,396Peptides directed for diagnosis and treatment of amyloid-associated disease
Term ended
Term ended Jan 16, 2023 · USPTO record
Term endedTerm ended Jan 16, 2023USPTO record
10 of 45 patents shown.
Pro members see all 45.
Pro members: see all 45 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited